欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号EE/V/0106/001
药品名称Butasal-100
活性成分
    • butafosfan 100.0 mg/ml
    • cyanocobalamin 0.05 mg/ml
剂型Solution for injection
上市许可持有人Interchemie Werken De Adelaar Eesti AS Vanapere tee 14 Püünsi Village Viimsi Rural Municipality Harju County Estonia
参考成员国 - 产品名称Estonia (EE)
互认成员国 - 产品名称
    • Cyprus (CY)
    • France (FR)
      BUTASAL-100 100 MG/ML SOLUTION INJECTABLE POUR CHEVAUX BOVINS CHIENS ET CHATS
    • Czechia (CZ)
      Butasal-100 100 mg/ml + 0,05 mg/ml injekční roztok pro koně, skot, psy a kočky
    • Spain (ES)
    • Romania (RO)
    • Portugal (PT)
    • Slovakia (SK)
    • Italy (IT)
    • Slovenia (SI)
    • Greece (GR)
    • Croatia (HR)
    • Denmark (DK)
    • Sweden (SE)
    • United Kingdom (Northern Ireland) (XI)
    • Belgium (BE)
      Butasal-100
    • Norway (NO)
    • Netherlands (NL)
    • Finland (FI)
    • Iceland (IS)
      Butasal vet
    • Poland (PL)
    • Ireland (IE)
    • Hungary (HU)
    • Austria (AT)
      Butasal 100 mg/ml + 0,05 mg/ml Injektionslösung für Pferde, Rinder, Hunde und Katzen
许可日期2021/03/31
最近更新日期2022/01/21
药物ATC编码
    • QA12CX99 other mineral products, combinations
申请类型
  • TypeLevel1：food
  • TypeLevel2：Pharmaceutical
  • TypeLevel3：Other Generic application Art 13.3 Dir 2001/82/EC
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase